Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00938054 · ClinicalTrials.gov registry record

Identification of Characteristics Associated With Symptom Remission in Autism

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
37
Enrollment target

NCT00938054 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 37 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00938054 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
37 participants
Enrollment target

Study Summary

Autism is defined as a lifelong pervasive developmental disability, as such, symptom recovery is considered rare. Reports by Lovaas and McEachin, Smith \& Lovaas and more recently by Cohen, Amerine-Dickens, \& Smith, Smith Groen et al. and Sutera Pandey et al suggest that intensive behavioral intervention programs during preschool years may result in improvement to the point where some children no longer meet criteria for autism by the time they reach school age. Similarly, there are a large number of anecdotal reports of children with autism who, following intensive biomedical intervention (e.g., gluten/casein free diets, vitamin supplements, chelation), are indistinguishable from their typically developing peers. The goal of the current research is to characterize the behavioral and biological profiles of children with autism who show significant symptom reduction such that they no longer meet criteria for autism (Remitted Autism \[REM-AUT\]) and to contrast them with a group of children who continue to meet criteria for autism (AUT) and to typically developing (TD) group of children. Examining whether neurobiological and neurobehavioral symptoms commonly reported in autism are as frequent and severe in children who have responded to treatment is an important first step in determining what factors may contribute to symptom remission in autism. In addition, understanding how children with remitted autism compare to typically developing children will help us better understand whether symptom improvement is through remediation (normalization of function) or compensation (achieving the same behavioral/adaptive outcome but through an alternative process).

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2009-06-25
Est. Completion 2012-10-09

What the Registry Record Tells You About NCT00938054

The ClinicalTrials.gov registry entry for NCT00938054 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00938054 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00938054 about?

NCT00938054 is a clinical study titled "Identification of Characteristics Associated With Symptom Remission in Autism". Autism is defined as a lifelong pervasive developmental disability, as such, symptom recovery is considered rare. Reports by Lovaas and McEachin, Smith \& Lovaas and more recently by Cohen, Amerine-Dickens, \& Smith, Smith Groen et al. and Sutera Pandey et al suggest that intensive behavioral interv...

What is the current status of trial NCT00938054?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2009-06-25. Estimated completion is 2012-10-09.

Who is sponsoring clinical trial NCT00938054?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.